Join BioPlan Associates as we explore the latest trends, insights, and expert opinions on biopharmaceutical manufacturing.
From Single-use systems, Outsourcing, Capacity constraints, and much more, these podcasts dive into the most pressing issues and emerging opportunities from BioPlan's Annual Report and of Biopharmaceutical Manufacturing Capacity and Production, the most comprehensive, longest-running study of bioprocessing professionals.
Listen here!
Challenges Faced by CDMOs BWS Dialogues Podcast [Nov 4, 2025]
Eric Langer, president and managing partner of BioPlan Associates, shares his insights — backed by 20 years of data from the Annual Report of Biopharmaceutical Manufacturing Capacity and Production. Eric assesses the particular challenges faced by CDMOs, the role of geopolitics — including changes to H-1B visa rules — and job seekers’ emotional outlook, while putting it all into historical context. Created by Laura Bush, Marketing Director at Bandwidth Solutions.
Listen here! - Discovery Matters Podcast with CPhI [2021]
Dodi Axelson, Discovery Matters Podcast, and Eric Langer, President and Managing Partner of BioPlan Associates talk about highlights and trends from the 2021 Annual Report on Biopharmaceutical Manufacturing Capacity and Production.
Listen here! Drug Digest: Changes and Trends in the Outsourcing Landscape [2024]
In this episode of Drug Digest, Eric S. Langer, president and managing partner, BioPlan Associates discusses the current outsourcing landscape in the post-COVID world and the changes the pandemic has enforced in the demand for outsourced bioprocessing services.
4-part Educational Series - China's Emergence in Global Biopharma Manufacturing: Trends in the Chinese Biopharma Series [2019]
This four-part educational series, sponsored by BioProcess International and BioPlan Associates, Inc., highlights key trends emerging in China biopharmaceuticals, using select content from BioPlan Associates’ 2018 2nd edition report, Advances in Biopharmaceutical Technology in China, 2nd Ed., a unique, peer-reviewed study that incorporates the research and work from over 100 global industry expert authors, many based in China.
In Part 1, Michael Frizberg, President, CMAB – Switzerland and Hong Kong, highlights key drivers and areas of growth in China biopharma today, as well as cover areas of opportunities for expansion and revenue in today’s markets.
China Biopharma – Hot Bed for Investments - Watch Now
In Part 2, Dr. Linda Pullan, Principal, Pullan Consulting, covers China investments, as well as advice for negotiating China deals.
China’s GMP Strategies: Dealing with Quality Management Issues - Watch Now
In Part 3, Fai Poon, President, QuaCell Biotech, Ltd., covers China regulatory issues, a review of current challenges in biopharma quality management in China, and opportunities for progress with growing CMO platforms and emerging CQO business.
Bioprocessing Challenges and CMO Opportunities - Watch Now
In Part 4, Dr. Scott Wheelwright, Co-Founder and Principal, Complya Asia, provides an overview of factors affecting manufacturing, manufacturing trends by market, biopharmaceutical manufacturing in China among CMOs and developing companies.
